ArticleMolecular cancer2025

BCL-2 dependence is a favorable predictive marker of response to therapy for chronic lymphocytic leukemia.

Stephen Jun Fei Chong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.